Anti-Fibrotic Wound Closure Strategy (AFWCS)

DBI STANDARD OPERATING PROCEDURE (SOP)

Procedure Class: Regenerative Trauma Reconstruction Protocol

Clinical Domain: Trauma Surgery, Reconstructive Surgery, Orthopedic Trauma, Emergency Surgery, Wound Management

Frameworks Applied (MANDATORY)

Decentralized Biological Intelligence (DBI)
Fault-Tier Surgical Decision Engine (FT-SDE)
Synergistic Compatibility Framework (SCF)
PCR Therapeutic Logic (Preventative–Curative–Restorative)

1. PURPOSE & DBI WOUND HEALING PHILOSOPHY

1.1 Purpose

The Anti-Fibrotic Wound Closure Strategy is designed to:

Reduce post-traumatic fibrosis and scar formation
Preserve extracellular matrix architecture
Maintain microvascular perfusion networks
Minimize mechanical tension across wound edges
Support regenerative tissue remodeling

1.2 DBI Core Rule

Wounds heal with minimal fibrosis when the structural ECM scaffold and perfusion networks remain intact.

Excessive mechanical tension or tissue trauma converts regenerative repair into fibrotic scar formation.

2. CLINICAL SCOPE

AFWCS applies to:

traumatic soft-tissue injuries
post-debridement wound closure
fasciotomy closure
reconstructive trauma surgery
large surgical wounds
complex limb trauma

Particularly important in:

high-energy soft-tissue trauma
large tissue defects
fasciotomy wounds
polytrauma patients

3. BIOLOGIC BASIS OF FIBROSIS

Fibrosis occurs when wound healing shifts toward excess collagen deposition and scar formation.

Key triggers include:

Trigger	Outcome
excessive wound tension	collagen overproduction
ischemia	fibrotic repair
inflammatory activation	scar formation
ECM destruction	disorganized healing

Preventing these triggers promotes regenerative healing.

4. FAULT-TIER GOVERNANCE (FT-SDE)

Anti-fibrotic closure stabilizes multiple physiologic tiers.

Fault Tier	Surgical Objective
Tier 0 — Bioenergetic	maintain tissue oxygenation
Tier 1 — Perfusion	preserve microvascular supply
Tier 2 — Biomechanical	minimize mechanical tension
Tier 3 — Immune	reduce inflammatory activation
Tier 4 — Neural	protect sensory pathways

FT-SDE Rule

Wound closure must never compromise microvascular perfusion or increase tissue tension beyond physiologic tolerance.

5. DBI ANTI-FIBROTIC PRINCIPLES

Preserve extracellular matrix scaffold architecture
Maintain microvascular perfusion
Minimize tension across wound edges
Avoid excessive tissue compression
Promote layered physiologic closure

6. WOUND EDGE PREPARATION

Prior to closure:

confirm tissue viability
remove necrotic tissue selectively
preserve connective tissue scaffolds
ensure adequate perfusion

Excessive trimming of viable tissue should be avoided.

7. TENSION-FREE CLOSURE TECHNIQUE

Primary closure must prioritize low-tension approximation.

Strategies include:

Technique	Benefit
layered closure	distributes mechanical load
deep tension-relieving sutures	reduce surface stress
dermal approximation	stabilize wound edges
gradual wound edge alignment	prevent ischemia

8. PERFUSION PRESERVATION

During closure:

avoid tight sutures
preserve perforator vessels
maintain tissue oxygenation

Indicators of adequate perfusion include:

Indicator	Interpretation
capillary refill	perfusion intact
skin color	adequate blood flow
tissue temperature	oxygen delivery maintained

9. SUTURE MATERIAL SELECTION

Suture materials must minimize tissue trauma.

Preferred characteristics include:

Property	Purpose
atraumatic needles	reduce tissue damage
absorbable sutures	reduce chronic inflammation
low-tension suture patterns	preserve perfusion

10. STAGED WOUND CLOSURE

Complex wounds may require delayed or staged closure.

Advantages include:

improved tissue perfusion
reduced inflammatory response
decreased fibrosis risk

Staged strategies include:

delayed primary closure
gradual tension closure
secondary reconstruction

11. NEGATIVE PRESSURE SUPPORT

Negative pressure wound therapy may be used to:

promote tissue perfusion
reduce edema
support granulation tissue formation

This improves regenerative wound healing.

12. IMMUNE QUIETING EFFECT

Anti-fibrotic closure reduces:

cytokine activation
inflammatory infiltration
fibroblast overactivation

This supports balanced tissue remodeling.

13. POSTOPERATIVE MONITORING

Monitor wound healing indicators:

Parameter	Concern
perfusion	ischemia
wound tension	tissue stress
inflammation	infection risk
scar formation	fibrotic remodeling

Early intervention prevents fibrotic wound transformation.

14. COMPLICATION PREVENTION

Complication	Prevention
hypertrophic scarring	tension-free closure
tissue necrosis	perfusion preservation
wound dehiscence	layered closure
chronic fibrosis	ECM preservation

15. DOCUMENTATION REQUIREMENTS

Record:

wound characteristics
closure technique used
perfusion status
tension management strategy
postoperative wound plan
DBI compliance confirmation

16. SOP SUMMARY

The Anti-Fibrotic Wound Closure Strategy ensures that traumatic wounds are closed in a manner that preserves tissue architecture, maintains perfusion, and prevents excessive scar formation.

Within the DBI framework:

ECM scaffolds remain intact
microvascular networks are preserved
inflammatory activation is minimized
regenerative healing is promoted

This protocol forms a key component of the SCF regenerative trauma doctrine.